Go back to the public home page
Hello .
 U.S. 


  • News

    • International News

    • Education

    • Environment

    • Healthcare

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics
    and Policy

    • Government

    • Politics

    • Local Government

    • International Policy

  • Business
    and Economy

    • Economy

    • Finance

      • Stock Markets

    • Jobs and Labor

    • Company News

    • Industry News

      • Aerospace

      • Agriculture

      • Chemicals

      • Commodities

      • Construction and Engineering

      • Consumer Electronics

      • Defense

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable Energy

      • Financial Services

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Manufacturing

      • Information Technology

      • Metals and Mining

      • Pharmaceuticals and Biotechnology

      • Real Estate

      • Professional and Business Services

        • Legal

      • Telecommunications

      • Tobacco

      • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Forestry and Wood Industry

  • Arts
    and Culture

    • Art

    • Books and Literature

    • Entertainment

      • Cinema

      • Media

        • Radio and Television

      • Music

  • Lifestyle
    and Leisure

    • Automotive

    • Home and Garden

    • Fashion and Luxury

      • Textile and Apparel

    • Food

    • Travel and Hospitality

    • Boating and Yachting


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Racing

    • Rugby

    • Sailing

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

related announcements

News

  • Sellas Life Sciences Group Inc.

    Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]

  • Protalix BioTherapeutics Inc.

    Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]

  • Protalix BioTherapeutics Inc.

    Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]

More

Healthcare

  • 1Life Healthcare Inc.

    What To Know About Travel Vaccines

  • 1Life Healthcare Inc.

    Embarrassed to Talk to Your Doctor? 5 Tips For Addressing Awkward Topics

  • cbdMD Inc.

    Using Full Spectrum vs Broad Spectrum CBD for Sleep...

More

Cardinal Health Inc.

01/27/2022 | Press release | Distributed by Public on 01/27/2022 20:48

Cardinal Health earns perfect score on Human Rights Campaign Foundation's Corporate Equality Index for the 14th consecutive year

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

  • Newsvine
  • Digg
  • Delicious
  • StumbleUpon
  • Technorati
  • Buzz
  • Favorites
  • Google Reader

Please use the above public link if you want to share this noodl on another website.

Close

Smartlinks | Cardinal Health Inc. | News | Human Rights | Health | Social and Non-Profit | Human Rights | Local News | Human Rights | Jobs and Labor | Company News | Retail | Specialty Stores | Public Companies | Drug Retailers and Distributors | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | Bolsa de Comercio de Buenos Aires (BCBA) | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago | Bolsa Institucional de Valores (BIVA)

 Back

Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact